Dong Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dong Meng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Dandan Shi
Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, PR China
2 shared publicationsMengmeng Shang
Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, PR China
2 shared publicationsXiao Sun
Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, PR China
2 shared publicationsXiaoying Zhou
Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, PR China
2 shared publicationsJie Li
Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, PR China
1 shared publication- Jie Li
Department of Ultrasound, Qilu Hospital (Qingdao), Shandong University
1 shared publication
Latest Publications
- 21 November 2019
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (22) , 2957-2971
New FH peptide-modified Ultrasonic Nanobubbles for Delivery of Doxorubicin to cancer-associated Fibroblasts
Aim: To synthesize and evaluate a novel FH peptide-modified ultrasonic nanobubble-loading doxorubicin (FH-NB-DOX) for specially cancer-associated fibroblasts (CAFs) targeting and eradication. Materials & methods: The characteristics, cytotoxicity, contrast-enhanced ultrasound imaging (CEUI), targeting ability and specially eradicating CAFs of these NBs were investigated. Results: FH-NB-DOX (about 208 nm) showed a good CEUI, and achieved higher targeting ability due to the conjunction ability of FH peptide to tenascin C protein high-level expressed in CAFs. Under ultrasound irradiation, FH-NB-DOX could delivery more DOX into CAFs, thus exhibited stronger eradication role compared with NB-DOX and free DOX. Conclusion: These new NBs, which combines the advantages of targeted theranostic agent and CEUI, is expected to be a potential approach for tumor therapy based on CAF targeting.
- 21 November 2019
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (22) , 2957-2971
New FH peptide-modified Ultrasonic Nanobubbles for Delivery of Doxorubicin to cancer-associated Fibroblasts
Aim: To synthesize and evaluate a novel FH peptide-modified ultrasonic nanobubble-loading doxorubicin (FH-NB-DOX) for specially cancer-associated fibroblasts (CAFs) targeting and eradication. Materials & methods: The characteristics, cytotoxicity, contrast-enhanced ultrasound imaging (CEUI), targeting ability and specially eradicating CAFs of these NBs were investigated. Results: FH-NB-DOX (about 208 nm) showed a good CEUI, and achieved higher targeting ability due to the conjunction ability of FH peptide to tenascin C protein high-level expressed in CAFs. Under ultrasound irradiation, FH-NB-DOX could delivery more DOX into CAFs, thus exhibited stronger eradication role compared with NB-DOX and free DOX. Conclusion: These new NBs, which combines the advantages of targeted theranostic agent and CEUI, is expected to be a potential approach for tumor therapy based on CAF targeting.
- 4 July 2019
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (19) , 2549-2565
Charge-conversion and ultrasound-responsive O-carboxymethyl Chitosan Nanodroplets for Controlled Drug Delivery
Aim: O-carboxymethyl chitosan/perfluorohexane nanodroplets (O-CS NDs) and doxorubicin-loading O-carboxymethyl chitosan nanodroplets were synthesized and functionally tested as drug delivery system ... Graphical abstract
- 4 July 2019
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (19) , 2549-2565
Charge-conversion and ultrasound-responsive O-carboxymethyl Chitosan Nanodroplets for Controlled Drug Delivery
Aim: O-carboxymethyl chitosan/perfluorohexane nanodroplets (O-CS NDs) and doxorubicin-loading O-carboxymethyl chitosan nanodroplets were synthesized and functionally tested as drug delivery system ... Graphical abstract